Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for pelvic pain in endometriosis
IRCT20091012002576N39Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cabergoline in endometriosis, sponsored by Tehran University of Medical Sciences. Primary endpoint: Pelvic pain intensity. Started Apr 2024; status: completed.
02
Drugs
cabergoline
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20091012002576N39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N39.